ILMN: Illumina Projected Price to Earnings

ILMN (Illumina, Inc.) - company brandmark

Illumina, Inc. (ILMN) maintains its leadership in genomics by leveraging affordable sequencing to lock customers into expensive reagents. The company's forward P/E ratio visualizes this strategy, where 33.50 shapes the current metric. Growth will be driven by NovaSeq X and optimization following the divestiture of Grail. Patent protection for NGS systems and a massive installed base guarantee a steady stream of profit from consumables.

Market Cap to Projected Earnings: illumina.com (ILMN) for 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company Illumina, Inc. (ILMN)

- stock value and consensus price forecast:
Basic company analysis:ILMN Illumina Corp
Signature product of Illumina Platform

The "razor-and-blade" model of Illumina, Inc. (ILMN) ensures a stable cash flow through the sale of consumables for installed sequencers. By analyzing the company's forward P/E ratio on GURU.Markets, an investor assesses the asset's market value relative to future earnings. This metric is calculated as the ratio of market capitalization to projected annual net income. A declining curve signals either undervaluation or rising risks. This is a key tool for determining the fundamental potential of the business.

Competing companies

Forward P/E Multiple A|DGX - Projected Price to Earnings Ratio|Exact Sciences Corp - Projected Price to Earnings|revvity.com (RVTY) - Projected Price to Earnings Ratio|Bio-Rad Laboratories, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings Anbio NNNN|Nordion (SHC) - Future Price to Earnings|QDEL - Market Cap to Projected Earnings|Future Price to Earnings OPKO Health Inc|CareDx (CDNA) - Market Cap to Projected Earnings|Future Price to Earnings Maravai LifeSciences Holdings (MRVI)|FLGT: Price to Expected Earnings Ratio|Forward P/E Multiple LAB (Standard BioTools Inc)|Cytek Biosciences, Inc. (CTKB) - Projected Price to Earnings Ratio|OraSure Corp - Forward P/E Multiple|Forward Price to Earnings Multiple exagen.com (XGN)|MDXH: Forward P/E Multiple|LUCD - Market Cap to Projected Earnings|Projected Price to Earnings PRE|IMDX - Forward Price to Earnings Multiple|Projected Price to Earnings TRIB (Trinity Biotech plc)|Forward P/E Multiple prophaselabs.com (PRPH)|Forward P/E Multiple AIMD (Ainos Inc)|Forward Price to Earnings Multiple Co-Diagnostics Inc|heartsciences.com - Forward P/E Multiple|Biomerica, Inc (BMRA) - Projected Price to Earnings|CDIO: Forward P/E Multiple|Price to Future Earnings Ratio ONCO|Future Price to Earnings Virax Biolabs|Bluejay Diagnostics, Inc. (BJDX) - Market Cap to Projected Earnings|Future Price to Earnings Aspira Women's Health (AWH)|AXDX (Accelerate Diagnostics, Inc) - Future Price to Earnings Multiple|CENTOGENE, N.V. - Projected Price to Earnings|Future Price to Earnings Multiple ENZ|Future Price to Earnings Multiple fresh2.co (FRES)|GENE (Genetic Technologies Limited) - Price to Future Earnings Ratio|ME: Forward P/E Multiple|Price to Future Earnings Ratio PMD